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Bet is a foamy virus (FV) accessory protein not required for virus replication. The function of Bet is not understood.
We report on the generation of cell lines stably expressing the HFV Bet protein. In Bet1 cells, HFV replication was
reduced by ;3–4 orders of magnitude compared with control cells. The HFV Bet-expressing cells only partially resisted
infection by the distantly related feline FV (FFV). Pseudotyping experiments, using murine retroviral vectors with an HFV
envelope, revealed that the resistance was not due to downregulation of the unknown HFV receptor. In transfection
experiments, using proviral reporter gene constructs and infectious proviruses, no significant differences were detected
between Bet1 and control cells. In infection experiments, HFV vectors expressing an indicator gene under control of the
HFV promoters showed no activity in Bet1 cells. The results are best compatible with the hypothesis that the main block
to productive superinfection of Bet1 cells occurs at an early stage of replication between virus entry and provirus
establishment. We suggest that inhibition of provirus integration by Bet protein may serve a distinct function in the
unique foamy virus replication cycle. © 1998 Academic Press
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INTRODUCTION
The foamy viruses (FVs) have gained increasing
scientific interest because of their unusual replication
strategy, which is without precedent among animal
viruses (Rethwilm, 1996; Weiss, 1996). Although in its
proviral form the FV genome organization is similar to
known retroviruses, there exist significant functional
dissimilarities in the way of replication, which have
been addressed in recent studies (Baldwin and Linial,
1998; Bodem et al., 1996; Enssle et al., 1996; Fischer et
al., 1998; Goepfert et al., 1995, 1997; Heinkelein et al.,
1998; Jordan et al., 1996; Konvalinka et al., 1995; Lo¨ch-
elt and Flu¨gel, 1996; Moebes et al., 1997; Schliephake
and Rethwilm, 1994; Yu et al., 1996a). The finding that
FVs can reverse transcribe their RNA pregenome late
in the replication cycle, which results in DNA as the
functional virion nucleic acid (Moebes et al., 1997),
highlights their unique properties among retroviruses.
The FV genome is complex (Cullen, 1991; Rethwilm,
1995). In addition to the canonical retroviral gag, pol,
and env genes, two accessory open reading frames
(ORFs) are located between the env gene and the 39
long terminal repeat (LTR) (Rethwilm, 1995). ORF 1
encodes for a DNA binding protein, Tas (for transac-
tivator of spumaviruses), which is a potent activator of
gene expression from the LTR and the internal pro-
moter (IP) (He et al., 1996; Kang et al., 1998; Rethwilm,
1995; Zou and Luciw, 1996). The IP is located in the env
gene upstream of the accessory genes of FVs and
directs their gene expression in the initial phase of
replication (Lo¨chelt et al., 1993, 1994). Tas is required
for FV replication (Baunach et al., 1993; Yu and Linial,
1993). ORF 2 encodes for the main part of the so-called
Bet protein. Bet is translated from a multispliced
mRNA, which uses a very efficient splicing event to
fuse an ORF 1 exon to an ORF 2 exon (Fig. 1)(Hahn et
al., 1994; Muranyi and Flu¨gel, 1991). In the case of HFV
Bet, 88 amino acids are contributed by ORF 1, whereas
394 amino acids are contributed by ORF 2 (Hahn et al.,
1994; Muranyi and Flu¨gel, 1991). The 60-kDa Bet pro-
tein is highly expressed in lytically FV-infected cells; it
can be easily detected by antisera generated against
recombinant ORF 1 or ORF 2 proteins; and a robust
humoral immune response against Bet is generally
seen in FV-infected primates (Baunach et al., 1993;
Hahn et al., 1994; Ro¨sener et al., 1996). All this points
to an important role of Bet for virus replication. How-
ever, the phenotypical analysis revealed that Bet2
viruses replicate in cell culture to titers only 10-fold
less, if reduced at all, compared with wild-type virus,
and the function of Bet is not understood (Adachi et al.,
1995; Baunach et al., 1993; Lee et al., 1994; Schmidt
and Rethwilm, 1995; Yu and Linial, 1993).
Interestingly, a Tas defective FV genome (DFV) has
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been identified that resulted from reverse transcription
of a pregenomic RNA from which the Bet intron was
spliced out (Bodem et al., 1998; Herchenro¨der et al.,
1996; Saib et al., 1993). DHFV was shown to behave
like a defective interfering (DI) virus, and cell lines with
integrated copies of DHFV were found to be resistant
to lytic HFV superinfection (Saib et al., 1995). This
resistance strongly depended on the number of inte-
grated DHFV copies. No protein expression from the
transactivator defective provirus could be detected.
However, low levels of the 2.2-kb Bet mRNA were
found in resistant cells, which harbored $15 copies of
DHFV. Because DHFV cell lines with a mutated Bet
failed to show the resistant phenotype, a role of Bet in
mediating the resistance was suggested (Saib et al.,
1995).
To extend these studies and to get a better under-
standing of Bet function, we analyzed whether cells ex-
pressing only Bet are resistant to FV superinfection and,
in the case of a positive result, to determine the nature of
this block. For this study, we used the so-called HFV
isolate because of the availability of HFV-related re-
agents. However, it is worth noting that HFV most likely
represents a chimpanzee virus isolate of FVs (Bieniasz et
al., 1995; Herchenro¨der et al., 1994) and that there is so
far a lack of evidence for naturally occurring human FV
infections (Ali et al., 1996; Ro¨sener et al., 1996; Schweizer
et al., 1995).
RESULTS
Establishment of HFV Bet-expressing cell lines
The bet cDNA was introduced into the pLEN retro-
viral vector, and following packaging in ecotropic
and amphotropic retroviral packaging cells, BHK-21,
KMST-6, and Vero A cells were stably transduced (Fig.
1). Indirect immunofluorescence using a rabbit anti-
serum generated against recombinant Tas protein re-
vealed strong cytoplasmic staining of the transduced
cells (data not shown). Single-cell clones were estab-
lished and probed by immunoblot. As shown in Fig. 1,
the 60-kDa Bet protein was detected in lysates from
the individual cell clones, which were used in further
studies. Only one tenth of a lysate from lytically HFV-
infected cells was necessary to produce on reaction
with the antibody in an immunoblot a signal of the
FIG. 1. Generation of Bet-expressing cell lines. (A) 39 HFV genomic region. (B) The bet cDNA was inserted into the retroviral vector pLEN. After
transfection of retroviral packaging cells, the supernatant was used to transduce KMST-6, BHK-21, and Vero A cells. KMST-6 cells were also
transduced with vector only (KMST/neo). Single-cell clones were established by limiting dilution, and lysates from the cells (50 mg of protein) were
probed by immunoblot using a Bet reactive rabbit serum (C). A lysate from lytically HFV infected KMST-6 cells (5 mg of protein) was run as a positive
control. (IP) Internal promoter. (IRES) Internal ribosomal entry site present in the pLEN retroviral vector. (M) MunI restriction site. (E) EcoRI restriction
site.
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strength comparable with the lysates from the Bet1
cells (Fig. 1). Therefore the LEN/bet transduced stable
cell clones expressed approximately one tenth the
amount of Bet protein compared with lytically HFV-
infected cells.
Resistance of Bet1 cells to FV superinfection
Bet1 cells and control cells were infected with
HSRV2 (Schmidt and Rethwilm, 1995) at an m.o.i. of 0.2
and 1.0, and the cell-free virus was determined over
time in the supernatant using a sensitive blue cell
assay (Schmidt and Rethwilm, 1995). As shown in Fig.
2A, although Bet2 control cells produced appreciable
amounts of HFV, Bet1 cells produced on the average
3–4 orders of magnitude lower levels of virus. The
extent of this reduction appeared to correlate with the
amount of input virus. However, even after prolonged
(6 weeks) incubation of Bet1 cells infected with an
m.o.i. of 1.0, cell-free virus titers never exceeded 100/
ml. To analyze whether the HFV Bet-expressing cells
were resistant to infection by other FVs, the cells were
infected with FFV. Compared with HFV, FFV is the most
distantly related FV described to date; its gag, pol, and
env genes show only ;45%, ;65%, and ;55% nucle-
otide sequence identity, respectively (Helps and Har-
bour, 1997; Winkler et al., 1997). Replication of FFV was
determined on FK/LTR(FFV)lacZ cells by a blue cell
assay similar to HFV replication on BHK/LTR(HFV)lacZ
cells. As shown in Fig. 2B, HFV Bet1 cells, which were
infected at m.o.i. of 0.2 and 1.0, initially resisted FFV
replication. However, ;2 weeks after inoculation, the
cell-free FFV titers produced in Bet1 cells approached
those of the control cells. This breakthrough indicated
that HFV Bet is unable to keep FFV replication under
control.
Bet1 cells retain the FV receptor
It has been suggested that the function of Bet for FV
replication may be similar to the function of Nef for the
replication of primate lentiviruses (Rethwilm, 1995). CD4
receptor downregulation is one of the functions that have
been associated with Nef (Cullen, 1994). The FV receptor
is currently not known. To address the question of re-
ceptor downregulation by Bet protein, Bet1 and Bet2
cells were infected with a green fluorescent protein
(GFP) expressing murine leukemia virus (MLV) vector
that was pseudotyped either with the vesicular stomatitis
virus (VSV) G protein or with the chimeric HFVD2MuLV
envelope (Lindemann et al., 1997). Except for the cyto-
plasmic tail of the transmembrane protein (TM), which is
derived from MLV, the HFVD2MuLV envelope protein is
made up of the HFV surface and TM domains (Linde-
mann et al., 1997). Therefore, this chimeric envelope
must use the FV receptor to gain entry into cells. In the
event that Bet downregulates the FV receptor, Bet1 cells
should not allow efficient infection by HFVD2MuLV
pseudotyped virus, whereas the virus pseudotyped with
the VSV-G envelope should not be specifically affected
by Bet. As shown in Fig. 3, no significant differences to
infect Bet1 or Bet2 cells were found when using either of
the two envelopes. This indicated that receptor down-
regulation was probably not responsible for the resis-
tance of Bet1 cells to HFV superinfection.
HFV promoter activity after transfection of Bet1 cells
We next investigated whether the HFV promoters may
be silent in Bet1 cells. The cells were transfected with
pHSRV2 together with the indicator plasmid p59cat
(2777/14) (Erlwein and Rethwilm, 1993). Although some
differences between individual cell clones were ob-
served, the overall result obtained on transfection of
these plasmids indicated that these differences were
insignificant (Fig. 4). This suggested that Bet has no
major influence on the activity of the HFV promoters
when these are delivered to the cells as plasmids, which
is equivalent to a provirus.
Analysis of virus production in Bet1 cells after
transfection of infectious genomes
The infection of cells by wild-type virus indicates
that Bet is expressed to high levels throughout the
replication cycle (Hahn et al., 1994; Lo¨chelt et al., 1994;
Muranyi and Flu¨gel, 1991). Therefore it appears un-
likely that Bet inhibits virus replication by interfering
with late viral functions, such as particle assembly or
viral export. However, to determine more precisely
whether late viral functions were affected in Bet1
cells, we transiently transfected Bet1 and Bet2 BHK-21
cells with infectious HFV genomes and analyzed the
cell-free viral titers 48 h after transfection. As shown in
Fig. 5, Bet1 BHK-21 cells produced ;10–20 times less
infectious virus compared with the control cells. To
exclude the possibility that the observed difference
may result from secondary rounds of infection, we also
transfected the pMH9 plasmid into Bet1 and Bet2
BHK-21 cells. The plasmid pMH9 can only perform one
round of replication because it has a large deletion in
the U3 region of the 39 LTR. As shown in Fig. 5, we still
observed an ;4-fold difference in titers between Bet1
and Bet2 BHK-21 cells. The virus production after
transient transfections of KMST-6 and Vero A cells was
so low that differences between cell-free virus titers
produced by these cells and the corresponding Bet1
cells were insignificant (data not shown). We therefore
generated Bet-expressing 293 human fibroblasts cell
clones as we had done with BHK-21, KMST-6, and Vero
A cells. Our 293 cells did not support efficient HFV
replication (data not shown). However, transient virus
production after transfection of 293T cells (a derivative
of 293 cells) with infectious HFV genomes is very
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efficient (Lindemann and Rethwilm, 1998; Moebes et
al., 1997). When 293 cells were transfected with
pHSRV2 or pcHSRV2, no significant differences in ex-
tracellular titers were observed between Bet1 or Bet2
cells (Fig.5).
Although a minor effect on the late phase of virus
FIG. 2. Development of cell-free virus titers after infection of Bet2 and Bet1 cells with foamy viruses. The Bet2 and Bet1 cells were infected
with HFV (A) and FFV (B) at the indicated m.o.i., and the cell-free supernatant was monitored for infectious virus on LTRlacZ indicator cells.
Although control cells produced appreciable amounts of virus, Bet-expressing cells resisted a productive HFV infection even after prolonged
cultivation (6 weeks). Vero A cells, in particular when infected at low m.o.i., produced considerably lower amounts of cell-free HFV compared
with BHK-21 and KMST-6 cells. For this reason, the difference in the development of viral titers between Vero A and Vero/Bet1 cells was less
pronounced than that with the other cells (data not shown). In contrast, Bet1 cells resisted FFV replication only in the initial phase. The
development of viral titers in the supernatant of these cells was retarded compared with the control cells by 1–2 weeks.
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replication cannot be excluded, these results argue that
the resistant phenotype of Bet1 cells to HFV superinfec-
tion probably has other causes.
HFV promoter activity after infection of Bet1 cells
Recently, evidence as been presented indicating that
the functionally active genome of extracellular HFV con-
sists of largely double-stranded linear DNA (Moebes et
al., 1997). Because the effector plasmids in the transfec-
tion experiments presented in Figs. 4 and 5 delivered the
virus as naked viral DNA integrated into the plasmid
backbone, we wanted to know how viral DNA behaved
on infection of Bet1 cells. To analyze this and to dissect
more precisely the problem of Bet-mediated resistance
to FV superinfection, we performed infection experi-
ments with an indicator gene expressing HFV vector, as
illustrated in Fig. 6.
pFOV-7/gfp is a replication competent pFOV vector
(Schmidt and Rethwilm, 1995) directing the expression of
GFP as a fusion protein to a truncated Bet protein (Nes-
tler et al., 1997). The fusion partners are cleaved by an
autocatalytically active protease encoded at the junction
of the two proteins (Schmidt and Rethwilm, 1995). The
expression of the indicator gene is dependent on the
activity of the HFV promoters (Schmidt and Rethwilm,
1995). Infection of Bet2 cells resulted in a high percent-
age of GFP positive cells as detected by FACScan anal-
ysis after infection with FOV-7/gfp. However, when Bet1
cells were infected, no GFP-expressing cells above
background were detected (Fig. 6).
DISCUSSION
The results presented in this study showed that Bet-
expressing cells are resistant to productive HFV replica-
tion. However, whether the resistant phenotype of Bet1
cells is identical to that observed for DHFV-bearing cells
(Saib et al., 1995) cannot be deduced from our study
because different methods were applied to analyze virus
production. The inhibition of replication appeared to be
rather specific for the homologous virus because the
distantly related FFV was found able to replicate at least
partially in HFV Bet1 cells, and gene expression of an
MLV vector genome was not impaired. Although other
regions of the genomes are reasonably conserved, the
weak homology of ;20% between HFV and FFV Bet
(Bodem et al., 1998; Winkler et al., 1997) is likely respon-
sible for the lack of resistance of the HFV Bet1 cells to
FFV replication.
Analysis of the late phase of viral replication, that is,
after provirus integration, revealed only a minor differ-
ence between Bet2 and Bet1 cells, which we do not
consider to be the reason for the resistance of Bet1 cells
to HFV superinfection. Furthermore, it has been reported
that Bet has a positive rather than a negative effect on
viral export (Yu and Linial, 1993). In addition, we did not
find a significant difference between Bet1 and Bet2 cells
in HFV promoter activity, when the effector plasmids
were transfected into the cells. Interestingly, cells har-
boring human immunodeficiency virus (HIV) genes have
been reported that resisted productive HIV superinfec-
FIG. 3. Transduction efficiencies of Bet2 and Bet1 cells infected with an MLV retroviral vector pseudotyped with different envelope proteins. The
cells (2 3 104) were exposed to a GFP-encoding MLV retroviral vector pseudotyped with either the chimeric HFVD2MuLV or the VSV-G glycoprotein.
HFVD2MuLV env uses the HFV receptor. No differences in transduction efficiencies between the two envelope proteins were observed, indicating
that the HFV receptor expression on Bet1 cells is not reduced compared with Bet2 cells. The mean and standard error of three independent
experiments are shown.
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tion (Federico et al., 1995). In this case, the block of
replication was recently shown to result from an impair-
ment in the generation of infectious progeny virus
(D’Aloja et al., 1998).
The most drastic difference between our Bet1 and
Bet2 cells was found on infection with an indicator gene
encoding virus. Although FOV-7/gfp expressed the indi-
cator gene in Bet2 cells, Bet1 cells resisted GFP expres-
sion. How can the apparent paradox of active HFV pro-
moters after transfection and the inactivity of these pro-
moters after infection be explained? Retroviral LTRs
require provirus integration for transcriptional activity
(Coffin, 1996). Furthermore, it has been shown recently
that HFV gene expression and replication require an
intact viral integrase (Enssle et al., 1998). Transfected
plasmid DNA harboring retroviral genomes behaves like
proviral DNA (Sakai et al., 1993). Therefore our results
strongly indicate that the Bet-mediated resistance to HFV
superinfection is mainly due to an inhibition in the early
phase of viral replication before provirus establishment.
However, we do not know at what specific stage before
integration Bet inhibits HFV replication. This may be at
the stage of completion of reverse transcription, trans-
port of the preintegration complex to specific sites of the
nuclear matrix, or provirus integration itself.
What might be the function of Bet in the FV replication
cycle? We regard the integration of multiple DFV ge-
nomes into the same cell (Saib et al., 1995) or of one or
a few copies into transcriptionally active genomic re-
gions, which may result in Bet expression, as too rare an
event in the infected host to have any major effect on the
survival and spreading of these horizontally transmitted
viruses, which can infect many different cell types
(Hooks and Gibbs, 1975). Evidently, such cells would be
resistant to FV superinfection (Saib et al., 1995). How-
ever, from the viewpoint of the virus, such a replication
block would be rather late because the superinfecting
virus could enter a cell and would be inhibited from
replication. This is in contrast to the situation found for
the primate lentiviral Nef protein, which is believed to
prevent superinfection by receptor downregulation and
thereby provide a selective advantage for the virus to
replicate in vivo (Cullen, 1994).
Bet is expressed from the provirus after integration.
This can lead to the idea that the phenomenon we
investigated may be a cell culture epiphenomenon not
related to any in vivo functions of Bet. Although we
cannot formally exclude this possibility, we suggest a
different explanation of our results, which may shed light
on one aspect of Bet function. Investigations on the FV
replication cycle have so far uncovered a variety of novel
aspects (Rethwilm, 1996; Weiss, 1996). The finding of
Gag protein recycling into the nucleus of already infected
cells (Schliephake and Rethwilm, 1994; Yu et al., 1996b)
has led to the suggestion that FVs may perform an
intracellular replication cycle similar to that demon-
strated for hepadnaviruses (Ganem, 1996; Rethwilm,
1996; Schliephake and Rethwilm, 1994). Furthermore, it
was observed that reverse transcription of the FV pre-
genomic RNA already occurs late in the replication cycle,
resulting in a considerable amount of unintegrated cop-
ies of virus DNA (Moebes et al., 1997). We recently
obtained genetic evidence for such an intracellular HFV
replication cycle (unpublished results). Although the ef-
ficiency of this replicative short cut is currently under
investigation, we assume that the inhibition of multiple
reintegrations into the host cell genome would be ad-
vantageous for the virus to avoid damage to the host cell
genome. Thus, controlled regulation of an intracellular
replication cycle would result in a higher virus release.
MATERIALS AND METHODS
Cells and viruses
Cell lines from baby hamster kidney (BHK-21), African
green monkey kidney (Vero A), feline kidney (CRFK),
human kidney (293 and 293T) (DuBridge et al., 1987), and
human skin (KMST-6) (Namba et al., 1985) were culti-
vated in Eagle’s minimal essential medium (MEM) or
Dulbecco’s modified Eagle’s medium (DMEM) containing
5–10% FCS and antibiotics. BHK/LTR(HFV)lacZ cells
(Schmidt and Rethwilm, 1995) were cultivated in MEM
containing 5% FCS and 1 mg/ml G418 (PAN Systems).
The retrovirus vector packaging cell lines GP1E-86
(Markowitz et al., 1988) and PA317 (Miller and Buttimore,
FIG. 4. Relative HFV promoter activity in Bet1 and control cells. The
cells were cotransfected with the infectious proviral clone pHSRV2
(Schmidt and Rethwilm, 1995), the indicator gene construct
p59cat(2777/14)(Erlwein and Rethwilm, 1993), and the b-galactosi-
dase-encoding plasmid pCH110. CAT values were normalized for dif-
ferences in transfection efficiencies. Values obtained for the control
cells were arbitrarily set to 1. Some differences between Bet2 and Bet1
cells can be seen, such as, between KMST/neo and KMST/Bet2 cells,
which may reflect clonal variation. However, taking all results together,
the differences between Bet-expressing and nonexpressing cells are
not significant and cannot explain the differences observed in the
development in viral titers (Fig. 2).
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1986) were cultivated in DMEM containing 10% FCS and
HAT (100 mM hypoxanthine, 0.4 mM aminopterin, 16 mM
thymidine) in the case of PA317 cells. HFV plasmid-
derived viruses were generated by CaPO4-mediated
transfection of BHK-21 or 293T cells (Ausubel et al., 1987)
and were abbreviated with the plasmid name lacking the
FIG. 5. Release of cell-free virus after transfection of Bet2 and Bet1 cells with infectious HFV genomes. The cells were transfected with the depicted
infectious genomes. In contrast to pHSRV2 and pcHSRV2, pMH9 can only perform one round of replication due to a large deletion in the U3 region
of the 39LTR. The U3-GFP cassette in pMH9 is irrelevant for this experiment. At 48 h after transfection, the virus in the cell-free supernatant was titered
on BHK/LTR(HFV)lacZ indicator cells. The results from three independent experiments are shown. Transient transfection of 293 cells with pHSRV2
yielded only very low amounts of virus. These cells also fail to support productive HFV replication. However, virus yields after transfection of these
cells with pcHSRV2 were in the same range obtained by transfection of 293T cells with this plasmid (Lindemann and Rethwilm, 1998; Moebes et al.,
1997). (IP) Internal promoter.
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“p.” The uncloned FFV isolate (Chiswell and Pringle,
1978) was grown on CRFK cells. Cell-free (0.45-mm fil-
trate) virus preparations were stored at 270°C for use.
HFV titrations were performed on BHK/LTR(HFV)lacZ
cells as described previously (Schmidt and Rethwilm,
1995). FK/LTR(FFV)lacZ cells are CRFK cells with an
integrated lacZ gene under control of the FFV U3 region.
The generation of this cell line is described below. It was
used to titrate FFV in a similar way to the titration of HFV
on BHK/LTR(HFV)lacZ cells (Schmidt and Rethwilm,
1995), except that 8 3 104 FK/LTR(FFV)lacZ cells per well
were seeded onto 12-well plates (Nunc) the day before
inoculation with virus instead of 2.5 3 104 BHK/LTR-
(HFV)lacZ cells.
Generation of Bet protein-expressing cells
After the insertion of MunI linkers upstream and down-
stream of the repaired bet insert of the HFV cDNA clone
pA65 (Hahn et al., 1994), the complete bet coding se-
quence (EMBL accession number X79000) was inserted
as a 1.56-kb MunI fragment into the EcoRI cloning site of
the retroviral vector pLEN (Adam and Miller, 1991). pLEN-
bet(HFV) was transfected into the ecotropic packaging
cell line GP1E-86 using CaPO4 (Ausubel et al., 1987).
The supernatant of the transfected cells was used to
transduce the amphotropic packaging cell line PA317,
which was selected in 0.5 mg/ml G418. The supernatant
of the pooled G418-resistant PA317 packaging cells was
FIG. 6. Transduction efficiencies of Bet2 and Bet1 cells infected with GFP-expressing HFV vector. (A) A 39region of the pFOV-7/gfp vector. GFP is
initially expressed as a fusion protein to a truncated Bet protein. The fusion partners are cleaved by the cis-encoded 2A protease derived from
foot-and-mouth-disease virus (Schmidt and Rethwilm, 1995). (B) 2 3 104 Bet1 and Bet2 cells were infected with cell-free vector virus at an m.o.i. of
1.5, and the GFP expression levels were determined 72 h later by FACScan analysis. The results of three independent experiments are presented.
(C) Examples of the FACS images demonstrating the lack of activity of FOV-7/gfp in expressing the indicator gene in Bet1 cells. The forward scatter
is shown on the x axis, and the fluorescence intensity is shown on the y axis.
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used to generate Bet protein expressing BHK-21, Vero A,
KMST-6, and 293 cells. The cells were selected in 0.5
mg/ml G418, and single-cell clones were established by
limiting dilution.
The expression of the Bet protein in the packaging
cells and in the transduced target cells was monitored by
indirect immunofluorescence using a rabbit antiserum
generated against recombinant ORF-1 protein as de-
scribed (Baunach et al., 1993). In addition, Bet expression
in the stable transduced single cell clones was analyzed
by immunoblot using the same antiserum (Hahn et al.,
1994).
Recombinant DNA
All recombinant DNA work was done by established
techniques (Ausubel et al., 1987). The vector pFOV-7/gfp,
which expresses GFP (S65T) (Chalfie et al., 1994; Linde-
mann et al., 1997) under control of the HFV LTR and IP,
has been described recently (Nestler et al., 1997). pMH9
is a derivative of pcHSRV2 (Lindemann and Rethwilm,
1998; Moebes et al., 1997), which harbors the internal
spleen focus forming virus (SFFV) U3/gfp expression
cassette (Baum et al., 1997; Fischer et al., 1998; Heinke-
lein et al., 1998) and has a deletion of a 0.56-kb BstEII–
XbaI fragment from the 39LTR U3 region.
The FFV U3-R fragment from 21070 to 148 was PCR
amplified from DNA of FFV-infected CRFK cells using
primers derived from the published FFV LTR sequence
(Bodem et al., 1996). A BglII site (underlined) was at-
tached to the 59 primer (59-GCAGATCTTGTCATGGGC-
CAAAGAGAATTC), and a KpnI site (underlined) was at-
tached to the 39 primer (59-GCGGTACCAGAGTCT-
CAATCTCACCCTGG). The lacZ gene from pCMVb
(Clonetech) was excised as a 3.53-kb NotI fragment and
inserted into the NotI site of a pcDNA vector harboring
the zeocine resistance cassette (InVitrogen). The CMV
enhancer–promoter was excised from this plasmid as a
0.9-kb BglII–KpnI fragment, and the 1.12-kb BglII–KpnI-
digested amplicon containing the FFV U3 region was
inserted. The resulting plasmid was linearized with BglII
and used to generate a stable transfected CRFK cell
clone by limiting dilution on selection in 400 mg/ml zeo-
cine (Eurogentec), similar to the previously described
BHK/LTR(HFV)lacZ cells (Schmidt and Rethwilm, 1995).
Infection experiments
The cells were infected with replication competent
cell-free virus at the m.o.i. indicated in the figure legends.
Virus replication was monitored by transferring cell-free
supernatant (0.45-mm filtrate) to the indicator cell lines.
The MLV-derived retroviral vector pSFG.GFPS65T (Linde-
mann et al., 1997) was packaged using the pHIT trans-
fection system (Soneoka et al., 1995) and was
pseudotyped with the VSV G protein using pHIT.VSV-G or
with the chimeric HFV env construct pCenv.HFVD2MuLV
(Lindemann et al., 1997). The virus-containing superna-
tant was divided into equal parts and used to infect an
equal number (2 3 104) of Bet1 and Bet2 cells. The
recipient GFP-expressing cells were identified 72 h after
transduction or infection by fluorescence-activated cell
sorting on a FACScan. The number of positive cells was
quantified by using the Lysis II and CellQuest software
packages (Becton Dickinson).
Transient transfection experiments
Next, 2 3 105 BHK-21 or 8 3 104 293 cells, which were
seeded onto six-well plates on the day before transfec-
tion, were transfected with 3 mg of HFV DNA, either
pHSRV2 (Schmidt and Rethwilm, 1995), pcHSRV2 (Linde-
mann et al., 1997; Moebes et al., 1997), or pMH9 (Fig. 4),
together with 2 mg of pCH110 (Hall et al., 1983) by CaPO4
cotransfection (Ausubel et al., 1987). Cell-free viral titers
(0.45-mm pore size filtrate) were determined 48 h after
transfection on BHK/LTR(HFV)lacZ cells. For CAT assays,
3 3 105 BHK-21, KMST-6, and Vero A cells were trans-
fected with 2 mg pf pHSRV2, 2 mg of p59cat(2777/14)
(Erlwein and Rethwilm, 1993), and 1 mg of pCH110 using
Lipofectin (GIBCO BRL). The CAT activity was determined
in cellular lysates as described previously (Erlwein and
Rethwilm, 1993). Cotransfection of the lacZ-encoding
plasmid pCH110 was done to account for different trans-
fection efficiencies. The results were normalized for sim-
ilar b-galactosidase expression levels, which were mea-
sured as reported previously (Norton and Coffin, 1985).
Results were obtained from three to eight independent
experiments and are presented in the figures as mean
values with standard error.
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